1, 3-Butanediol (BD) is converted in the body to !3-hydroxybutyrate, and previous studies have shown that hyperketonemia had beneficial effects in experi mental models of generalized hypoxia. The aim of this study was to determine if BD would reduce brain damage following cerebral ischemia. A transient forebrain isch emia of 30-min duration was induced by the four-vessel occlusion technique in control and BD-treated rats (25 mmoUkg, i.p.; 30 min prior to ischemia) . BD treatment led to significant improvement of neurologic deficit during the 72-h recovery period and reduced neuronal damage in the striatum and cortex but not in the CAl
Previous studies have shown that treatment with 1,3-butanediol (BD), an ethanol dimer (CH3-CHOH-CH2-CH20H), has beneficial effects in ex perimental models of hypoxia. It prolongs the sur vival time of mice exposed to 4-5% oxygen (Kirsch et aI., 1980) . It extends the time to isoelectric EEG and reduces the neurologic deficit in the ischemic hypoxic Levine rat (Lundy et aI., 1984; 1985) . BD is converted in the body to l3-hydroxybutyrate (Tate et aI., 1971) , and it has been proposed (Kirsch et aI., 1980 ) that attenuation of hypoxic damage is ac complished through a cerebral protective effect me diated by brain ketone metabolism. However, the possibility of a cardiac protective effect could not be ruled out in models of generalized hypoxia.
The aim of this study was to assess the effect of BD on a model of transient brain ischemia. The re-sector of the hippocampus. Evaluation of cerebral energy metabolism before and at the end of the ischemic period showed that the treatment did not change the preisch emic glycolytic and energy metabolite levels but atten uated the ischemia-induced metabolic alterations. It in creased energy charge, phosphocreatine, and glucose levels, and reduced lactate accumulation. The decrease in brain lactate concentration might account for the bene ficial effects of BD by minimizing the neuropathological consequences of lactic acidosis. Key Words: Brain metab olism-Butane diol-Cerebral ischemia-Ketone body -Neuropathology-Rat brain.
suIts indicate that BD pretreatment exerts benefi cial effects on neurologic deficit, histologic damage, and cerebral metabolic alterations induced by four-vessel occlusion in rats.
METHODS
The study was performed in male Wistar rats (lffa Credo), weighing 280-320 g, that were allowed free ac cess to water and food.
Production of cerebral ischemia
Cerebral ischemia was produced by the four-vessel oc clusion technique (Pulsinelli and Brierley, 1979) . The rats were anesthetized with ether, and the vertebral arteries were electrocauterized at the first cervical vertebrae. Four days later, both common carotid arteries were iso lated under ether anesthesia and atraumatic arterial clasps were placed around each. A polyethylene catheter was inserted into the tail artery for blood sampling and arterial blood pressure measurement. The animals recov ered from anesthesia for �6 h before the carotid clasps were tightened to produce four-vessel occlusion. Animals that did not become unresponsive within 60 s following clasp tightening were excluded from the study. Rectal temperature was measured throughout the ischemic pe riod and maintained at the preischemic value using a warming light. The carotid clasps were released 30 min later; restoration of carotid artery blood flow being vi sually verified. The rats were then placed in individual cages for 72 h, food was withheld during the 24-h period of recovery.
Neurologic deficit
A neurologic score (Table 1) was assessed 1 , 4, 8, 24, 48 , and 72 h after ischemia by an observer who was not aware of the treatment given to each rat. The examina tion consisted of neurologic reactions as described by Bures et ai. (1976) and of evaluation of the level of con sciousness and of motor function. The neurologic score was 20 for a normal rat.
Histopathology
Seventy-two hours after ischemia, the rats were anes thetized with chloral hydrate (360 mg/kg, i.p.), heparin ized (1, 000 VI, i.v.), and their brains were perfusion fixed with FAM (40% formaldehyde, glacial acetic acid, methanol; 1: 1:8 by vol) via the ascending aorta after washing out with physiological saline for 30 s (Brown and Brierley, 1968) . The brains were removed 4 h later and stored in FAM until they were embedded in paraffin. Co ronal sections (10 ILm) were taken through striatum at the level of the anterior commissure and through anterior hippocampus. Brain sections were stained with luxol fast blue and cresyl violet and examined with the light micro scope. Neuronal alterations were evaluated in three brain regions: (a) the dorsolateral crescent of the caudate nu cleus, (b) the CAl sector of the hippocampus, (c) the Pulsinelli et ai. (1982a) . The se verity of the ischemic lesions were graded on a scale from o to 3: 0, normal; 1, a few neurons damaged; 2, many neurons damaged; and 3, almost all neurons damaged. Each hemisphere was evaluated independently without the examiner knowing the experimental conditions.
Blood analysis
Ta il artery blood was sampled and immediately centri fuged at DoC. Plasma was deproteinized by addition of perchloric acid 35% (weight/volume), and the superna tant was used for enzymatic dosage of glucose (Lowry and Passoneau, 1972) and of D( -)-J3-hydroxybutyrate (Williamson et aI., 1962) .
Cerebral energy metabolites
The rats were initially anesthetized by inhalation of ether and were tracheotomized. Polyethylene catheters were inserted in the femoral arteries for continuous blood pressure recording and anaerobic blood sampling. A skin incision was made over the scalp to fit a plastic funnel over the skull bone for later in situ freezing of the brain according to the technique of Ponten et ai. (1973) . The administration of ether was discontinued after the end of the surgery, the animals were paralyzed (n-tubocurarine hydrochloride 1 mg/kg, i.v.) and connected to a respi rator that delivered 70% N20 and 30% 02' Arterial P02, Peo2, and pH were measured on 100 ILl blood samples using direct reading electrodes. Body temperature was kept close to 37"C by external heating. The animals were kept in respiratory steady state for at least 15 min, and the brains were frozen in situ by pouring liquid nitrogen into the plastic funnel for 3 min. Thereafter, animals were submersed in liquid nitrogen for another 5 min. Brains were chiselled out in the frozen state during intermittent irrigation with liquid nitrogen, the cerebral hemispheres were separated and stored in a liquid nitrogen freezer for subsequent metabolite assay.
The frozen hemispheres were weighed, homogenized in methanol-HCI at -2SOC and extracted twice with 0.3 N-perchloric acid at O°C (Folbergrova et aI., 1972) . The perchloric extracts were centrifuged at DoC, and the neu tralized supernatants were assayed for phosphocreatine (PCr), ATP, ADP, AMP, glucose, and lactate by enzy matic methods (Lowry and Passoneau, 1972) . The tissue residues were prepared and assayed for glycogen (Lust et aI., 1975) . The energy state of the tissue was calculated (Atkinson, 1968) in terms of the energy charge (EC) po tential of the adenine nucleotide pool (EC = ATP + 0.5 ADP/ATP + ADP + AMP).
Treatment BD (Prolabo) was diluted in distilled water and injected intraperitoneally (25 mmol/kg, 0.9 mlllOO g) 30 min before four-vessel occlusion. Control rats received an equivalent volume of saline.
Statistical analysis
The means and their standard errors were determined and compared by the two-tailed Student's t test. Differ ences in percentages of mortality and in grades of mor phologic damage were analyzed using the Fisher's exact test.
RESULTS

Mortality and neurologic deficit
From the 45 rats that were submitted to four vessel occlusion (22 saline controls and 23 BD treated rats), 6 controls, but no BD-treated rats, died throughout the ischemic period (p < 0.01). During the 48-h reperfusion period, seven controls and four BD-treated rats died; the death always being preceded by repetitive seizures. In the 48-72 h interval, none of the rats convulsed or died. Only the animals surviving 72 h were used for clinical evaluation, thus making the final neurologic re sponse an expression of quality of survival in each group.
The degree of clinical restitution in both groups is given in Ta ble 2. Control rats showed a more severe neurologic deficit than BD-treated rats. The differ ence between the two groups was significant from the twenty-fourth hour and persisted up to the sev enty-second hour after ischemia. At this time, the neurologic score was 11.2 in controls and 15.8 in the treated group (p < 0.01).
Histopathology
Brain damage was assessed 72 h after ischemia in 15 saline and 18 BD-treated rats. The BD-treated group was made up of the animals used for neuro logical examination minus one rat that died from anesthesia before brain perfusion. The saline treated group was made up of the nine animals that were used for neurological examination and six ad ditional rats that survived 72 h after 30-min of four vessel occlusion. BD treatment modified the distri bution of neuronal damage by reducing the severity of the histologic grade (Table 3 ). In the striatum, grade 3 damage was seen in 53% of controls and in 0% of BD-treated rats (p < 0.001). In the cortex, grade 3 damage was never seen in both groups, but grade 2 damage was seen in 67% of controls and 3.0 ± 0.9 8.1 ± J.l 9.7 ± 1.0 9.7 ± 2.0 11.2 ± 1.9 11.2 ± 1.6 BO-treated (n = 19)
2.0 ± 0.9 9.0 ± 1.0 11.0 ± 0.7 13.8 ± 0.8a 15.1 ± 0.7a 15.8 ± 0.8b
All rats were subjected to 30 min of four-vessel occlusion. BO (25 mmoVkg, i.p.) was injected 30 min before ischemia. Values expressed as means ± SEM. n, number of animals. a p < 0.05, bp < 0.01 between control and treated rats.
J Cereb Blood Flow Metabol, Vol. 7, No.6, 1987 only in 11% of treated rats (p < 0.05). The CAl sector of the hippocampus was the most damaged region. It showed grade 3 damage in 80% of con trols and in 61 % of treated rats, but the difference was not statistically significant.
Physiological and biochemical parameters BD injection led to an important and prolonged increase in plasma [3-hydroxybutyrate level ( Table  4 ). The level that was 0.20 mM/I in control rats in creased to 1.65 and 2.74 mM/I 30 and 60 min after BD injection, respectively.
Both controls and treated rats exhibited a marked and sustained increase in plasma glucose level during the ischemic period, but BD treatment did not significantly change the plasma glucose concentration either before or during ischemia (Table 4) .
BD treatment did not significantly alter the pre ischemic arterial blood pressure, but it decreased the hypertensive response induced by four-vessel occlusion (Table 4 ). Thus, MABP at 10 min of isch emia reached 160 mm Hg in the control group and only 135 mm Hg in the BD-treated group (p < 0.05). The difference between both groups was no more significant at 30 min of ischemia.
Cerebral energy metabolism
Cerebral energy metabolism was evaluated be fore and at the end of the ischemic period in saline and BD-treated rats. The physiological parameters were similar in the experimental groups (Table 5) except that arterial pH was significantly lower in BD-treated rats, probably as a consequence of the increase in blood ketone body level.
BD treatment did not affect the energy and gly colytic metabolites in nonischemic brains, but it at tenuated ischemia-induced metabolic changes ( Table 6 ). The treatment led to an increase in PCr (p < 0.05), glucose (p < 0.05), AT P (0.05 < P < 0.1), and energy charge (p <0.05), and to a decrease in ADP (p < 0.05), AMP (p < 0.01), and lactate level (17.35 j-Lmol/g in treated rats vs. 22.47 in controls, p < 0.01).
DISCUSSION
The present study shows that pretreatment with BD reduces the neurologic deficit in rats subjected to 30 min of four-vessel occlusion. This improve ment of clinical restitution was associated with de crease in damage in neuronal populations known to be selectively vulnerable to ischemic injury. The distribution and the nature of neuropathological changes seen in untreated rats are in accordance with those of Pulsinelli et al. (1982a) for the same 13  33  27  67a  13  II  2  27  33  67  lib  7  17  3  53  Oc  0  0  80  61 All rats were subjected to 30 min of four-vessel occlusion followed by 72 h of recirculation. BD (25 mmollkg. i.p.) was injected 30 min before ischemia. n, number of animals. a p < 0.05, bp < 0.01, cp < 0.001 between control and BD-treated rats (Fischer's exact test).
experimental model. BD treatment reduced neu ronal damage in the striatum and the cortex but failed to reduce the severity of damage in the CA 1 sector of the hippocampus. It is well known that this brain region is particularly vulnerable to isch emia and that it is altered even after short periods (5-10 min) of ischemia (Smith et aI., 1984) . The study of histologic alterations induced by 20 and 30 min of four-vessel occlusion in rats (Pulsinelli et aI., 1982a) showed that the extent of neuronal lesions was related to the duration of the ischemic period in the striatum and cortex but not in the CA 1 sector of the hippocampus. In this region, the frequency of grade 3 damage was similar after 20 min (85%) and 30 min (86%) of ischemia. This lack of relationship between neuronal damage and duration of the isch emic period might explain the difficulty of seeing a protective effect at the hippocampus level in rats subjected to 30 min of four-vessel occlusion. Im provement of neurologic deficit despite severe hip pocampal damage suggests that this brain region Plasma levels of f)-hydroxybutyrate and glucose and arterial blood pressure in control and 1,3butanediol (BD)-treated rats before and during ischemia Number of animals is nine for each group.
"p < 0.001, bp < 0.05 between control and BD-treated rats.
does not play a major role in the sensory-motor functions tested in our neurologic score. A decrease of mortality and neurologic deficit by BD pretreatment has been previously reported in the ischemic-hypoxic rat model of Levine (Lundy et aI., 1985) . The authors interpreted the beneficial effect as the consequence of a cerebral effect, but the possibility of a cardiac protective effect could not be ruled out. Indeed, the outcome of animals SUbjected to generalized hypoxia is markedly in fluenced by cardiac function, which governs brain blood delivery. The results of this study evidence a cerebral effect of BD as its efficiency was demon strated in a model of brain ischemia. The beneficial effect was seen with a dose of BD (25 mmol/kg) that was lower than that given by Lundy et al. [47 mmollkg, (1984; 1985) ]. The choice of this dose was made from preliminary experiments that showed signs of sedation in rats after intraperitoneal BD in jections of 50 mmollkg.
Attenuation of ischemic brain damage by BD treatment may theoretically involve hemodynamic or metabolic mechanisms. An increase in CBF during the ischemic period might explain beneficial effects. Four-vessel occlusion induces a severe but incomplete forebrain ischemia, with the residual blood flow in the rat strain used in this study aver aging 4-5% of the preischemic flow in the cerebral hemispheres . Lundy et al. (1984) reported that BD injection (47 mmollkg, i.v.) led to a significant fall in MABP, and the effect was interpreted as a consequence of a generalized vaso dilatation. With the intraperitoneal dose of 25 mmol/kg, BD had no hypotensive effect in non ischemic rats but reduced the hypertensive re sponse after four-vessel occlusion. Although CBF was not measured during ischemia, it seems un likely that a cerebral vasodilator effect of BD may induce an increase in residual CBF. In severe isch emic conditions, the cerebrovascular bed is maxi- 7.37 ± 0.01 37 ± 1 120 ± 11 143 ± 13 37.0 ± 0.2 7.31 ± 0.02b 36 ± 1 140 ± 10 124 ± 4 142 ± 3 131 ± 16 37.0 ± 0.2 36.5 ± 0.2 Data were obtained from mechanically ventilated rats (70% N20, 30% 02)' before and after 30 min of four-vessel occlusion. BD (25 mmoVkg, i.p.) was injected 30 min before ischemia. Values expressed as means ± SEM. n, number of animals. a p < 0.001, bp < 0.05 between control and BD-treated rats.
mally dilated, and the residual flow is only in fluenced by the perfusion pressure. In BD-treated rats, the reduction of the hypertensive response to ischemia would somewhat decrease the residual blood flow. The abrupt increase in arterial blood pressure produced by four-vessel occlusion may have a detrimental effect by producing acute pul monary edema, an effect frequently observed in the animals that died during the ischemic period. Thus, the decrease in the hypertensive response to vas cular occlusion might explain the reduction of the mortality observed during ischemia in BD-treated rats. Whereas BD treatment did not alter cerebral preischemic energy metabolite levels, it attenuated the metabolic changes induced by ischemia. It in creased PCr, glucose, and EC, and reduced lactate accumulation. The decrease in lactate concentra tion cannot be explained by either a decrease of plasma glucose level or by a decrease in cerebral preischemic glucose or glycogen stores, as these parameters were not modified by BD treatment. An increase in cerebral glucose availability secondary to glucose load (Myers and Yamaguchi, 1977; Siem kowicz and Hansen, 1978; Ginsberg et aI., 1980; Welsh et aI., 1980; Pulsinelli et aI., 1982b) , glycerol (Bralet et aI., 1983) , or dexamethasone treatment (Koide et aI., 1986) exerts deleterious effects on the ischemic brain by increasing cerebral lactic aci dosis. It has been assumed that a critical lactic acid concentration of about 20 f.lmollg (Rehncrona et aI., 1981; Bralet et aI., 1987) might exert cytotoxic ef fects (Kalimo et aI., 1981) by decreasing intracel lular pH (Smith et aI., 1986) . Thus the decrease of brain lactate concentration from 22.5 to 17.4 f.lmol/ g following BD injection might account for the ben eficial effect of the treatment by minimizing the neuropathological consequences of lactacidosis.
BD is converted in the liver to l3-hydroxybu tyrate by alcohol dehydrogenase and aldehyde de hydrogenase (Tate et aI., 1971) , and several data have suggested that the antihypoxic properties of BD were linked to its ketogenic effect. Ketosis in duced by a variety of methods such as fasting, dia betes, or ketogenic diet increased hypoxic survival time in rats (Myles, 1976) and mice (Kirsch and D'Alecy, 1979; Eiger et aI., 1980) . Ketone bodies can be used as an alternate substrate for brain me tabolism, and their rate of utilization seems to be regulated by their blood concentration and the ac- Ischemia of 30 min duration was induced by four-vessel occlusion. BD (25 mmol/kg, i.p.) was injected 30 min before ischemia. Concentrations are in fLmol/g wet tissue. Values expressed as means ± SEM. EC, energy charge; n, number of animals. a p < 0.05, bp < 0.01 between control and BD-treated rats.
tivity of their blood-brain transport system (Owen et aI., 1967; Hawkins et aI., 1971; Ruderman et aI., 1974; Cremer, 1982; Miller, 1986) . Following BD administration, a supplementary source of ketone would be the conversion of BD to [3-hydroxybu tyrate in brain, which contains the appropriate en zymes for this transformation (Raskin and Soko loff, 1970; .
In normoxic brains, the increase in ketone body oxidation leads to an increased lactate release from brain to blood (Owen et aI., 1967; Hawkins et aI., 1971; Ruderman et aI., 1974) and to a reduced gly colytic rate, probably due to inhibition of phospho fructokinase activity (Ruderman et aI., 1974; Di Vivo et aI., 1978; Miller et aI., 1982) . Though it is uncertain to what extent these mechanisms operate during ischemia, it has been shown that hyperke tonemia lowered brain lactate level in hypoxic mice (Kirsch and D'Alecy, 1983) . Studies performed on brain-slice preparations (Kirsch and D' Alecy, 1984) have shown an increased utilization of ketone bodies instead of glucose under hypoxic conditions.
Ta ken together, these data agree with the hy pothesis that preferential metabolism of ketones rather than glucose as an energy substrate may re duce the deleterious accumulation of brain lactic acid during ischemia. This hypothesis must be con firmed by further investigations to demonstrate the use of ketone bodies by the ischemic brain.
